410 Medical Raises $12 Million to Expand LifeFlow Infusion Technology

Jul 14, 2026
410 Medical has raised $12 million in financing led by Orlando Health Ventures, with funds aimed at expanding commercial operations and launching the next version of its LifeFlow infuser in 2027.

410 Medical has completed a $12 million financing round led by Orlando Health Ventures, announced in a press release. Participants in the round include Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General, and a new undisclosed strategic investor.

The funding will support 410 Medical's commercial operations and the launch of the next version of its LifeFlow infuser, expected in 2027. The company plans to expand its presence among hospital systems and emergency medical service agencies in the United States.

410 Medical’s LifeFlow system is used in more than 500 hospitals and EMS agencies for rapid delivery of fluids and blood to patients experiencing sepsis, hemorrhagic shock, or other critical conditions. The company reports that approximately 80,000 patients have been treated with LifeFlow devices to date.

Founded in 2013 and based in Durham, North Carolina, 410 Medical focuses on technologies that improve fluid resuscitation for critically ill patients. Its first LifeFlow system received FDA clearance in 2016.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.